15:43 Tue 17 Nov 2020
Deepverge PLC - Director/PDMR Shareholding
AIM share code: DVRG
17 November 2020
DeepVerge PLC
("DeepVerge" or "Company")
Director / PDMR shareholdings
Further to the announcement earlier today regarding the current level of acceptances from Modern Water plc ("Modern Water") shareholders and the allotment of shares relating to acceptances received in the last week, as a result of acceptance by
Following these allotments the shareholdings are as follows:
| Name | Shares acquired | Resulting Shareholding | Shares held as a % of enlarged share capital following Admission |
| G Brandon | 2,000,000 | 8,129,901 | 4.90% |
| N Burton | 1,200,000 | 1,883,167 | 1.14% |
The Company's total issued share capital, following the issue of the new Ordinary Shares will be 165,877,296. As the Company does not hold any shares in Treasury, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company following Admission.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
| a)
| Name
| | |||
| 2
| Reason for the notification
| ||||
| a)
| Position/status
| CEO | |||
| b)
| Initial notification /Amendment
| Initial notification | |||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
| a)
| Name
| DeepVerge plc | |||
| b)
| LEI
| 213800M477RQVVHVUD72 | |||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
| a)
| Description of the financial instrument, type of instrument | Ordinary shares of 0.1p each | |||
| | | ||||
| Identification code | GB00BMGWZY29 | ||||
| | | ||||
| b)
| Nature of the transaction
| Issue of Ordinary Shares | |||
| c)
| Price(s) and volume(s) | | | | |
| | | Price | Volume | | |
| |
| N/A | 2,000,000 | | |
| | | | | | |
| d)
| Aggregated information | N/A - single transaction | |||
| | | ||||
| - Aggregated volume | | ||||
| | | ||||
| - Price | | ||||
| | | ||||
| e)
| Date of the transaction
| | |||
| f)
| Place of the transaction
| Outside of a trading venue | |||
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
| a)
| Name
| Dr | |||
| 2
| Reason for the notification
| ||||
| a)
| Position/status
| Non-Executive Director | |||
| b)
| Initial notification /Amendment
| Initial notification | |||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
| a)
| Name
| DeepVerge plc | |||
| b)
| LEI
| 213800M477RQVVHVUD72 | |||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
| a)
| Description of the financial instrument, type of instrument | Ordinary shares of 0.1p each | |||
| | | ||||
| Identification code | GB00BMGWZY29 | ||||
| | | ||||
| b)
| Nature of the transaction
| Issue of Ordinary Shares | |||
| c)
| Price(s) and volume(s) | | | | |
| | | Price | Volume | | |
| |
| N/A | 1,200,000 | | |
| | | | | | |
| d)
| Aggregated information | N/A - single transaction | |||
| | | ||||
| - Aggregated volume | | ||||
| | | ||||
| - Price | | ||||
| | | ||||
| e)
| Date of the transaction
| | |||
| f)
| Place of the transaction
| Outside of a trading venue | |||
Enquiries
| DeepVerge plc | | +44 (0) 7340 055 648 |
| | | |
| SPARK Advisory Partners Limited (Nominated Adviser) | | +44 (0) 113 370 8974 |
| | | |
| Turner Pope Investments (TPI) Limited (Broker) | | +44 (0) 20 3657 0050 |
| | | |
About DeepVerge plc:
DeepVerge is a scientific research and AI-as-a-Service company focused on production and analysis of bacteria, virus and toxins utilising artificial intelligent data analytics in regulatory technology, from scientifically proving the impact of skincare product claims on skin microbiome for top 10 global cosmetic company clients to remotely detecting water contamination in real-time.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
FOR OUR FULL DISCLAIMER CLICK HEREDeep dive
